drugset / Trial / NCT02221648
Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
RandomizedParallel-groupTriple-blindTreatment
Summary
The scientific aim of this study is to investigate the efficacy of abobotulinumtoxinA (Dysport - Ipsen Pharmaceuticals) in chronic low back pain. The investigators hypothesis is that injection of Dysport brand of botulinum toxin type A into erector spinae muscles (extensors of the spine) can relieve low back pain through anti-spasm and analgesic effect of botulinum toxin.
Timeline
- Start
- 2012-12
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 1000 iu | Intramuscular |
Indications
No indication recorded.